Contact dermatitis (CD) affects ∼15% of the general population over a lifetime. However, there is a lack of epidemiological studies on treatment patterns for CD. We aim to analyze the patient characteristics and prescribing patterns among dermatologists and general practitioners (GPs) (internal medicine [IM] and family medicine [FM]) for CD in the United States. We conducted a population-based study using the National Ambulatory Medical Care Survey. We identified 178,017,680 weighted patient visits for CD from 2001 to 2016. Dermatologists saw more white and non-Hispanic patients than GPs. GPs were less likely to prescribe ultrahigh potency topical corticosteroids (FM OR 0.27; < 0.001, IM OR 0.41; < 0.001) and more likely to prescribe oral antihistamines (FM OR 3.71; < 0.001, IM OR 3.56; < 0.001), oral corticosteroids (FM OR 5.35; < 0.001, IM OR 6.87; < 0.001), and injectable corticosteroids (FM OR 3.42; = 0.006, IM OR 5.68; < 0.001) than dermatologists. Across CD visits, GPs were less likely than dermatologists to prescribe ultrahigh potency topical corticosteroids and more likely than dermatologists to prescribe oral antihistamines and systemic corticosteroid therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/derm.2024.0193 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!